Literature DB >> 17382318

The Cbl-interacting protein TULA inhibits dynamin-dependent endocytosis.

Vibeke Bertelsen1, Kamilla Breen, Kirsten Sandvig, Espen Stang, Inger Helene Madshus.   

Abstract

The Cbl- and ubiquitin-interacting protein T-cell ubiquitin ligand (TULA) has been demonstrated to inhibit endocytosis and downregulation of ligand-activated EGF receptor (EGFR) by impairing Cbl-induced ubiquitination. We presently report that TULA additionally inhibited clathrin-dependent endocytosis in general, as both uptake of transferrin (Tf) and low-density lipoprotein (LDL) was inhibited. Additionally, endocytosis of the raft proteins CD59 and major histocompatibility complex class I (MHC-I), which we demonstrate were mainly endocytosed clathrin-independently, but dynamin-dependently, was blocked in cells overexpressing TULA. By contrast, the uptake of ricin, which is mainly endocytosed clathrin- and dynamin-independently, was not affected by overexpressed TULA. Consistently, TULA and dynamin co-immunoprecipitated and colocalized intracellularly, and upon overexpression of dynamin the TULA-mediated inhibitory effect on endocytosis of Tf, LDL, CD59 and MHC-I was counteracted. Overexpressed dynamin did not restore ubiquitination of the EGFR, and consistently dynamin did not rescue endocytosis of the EGFR in cells overexpressing TULA. We conclude that TULA inhibits both clathrin-dependent and clathrin-independent endocytic pathways by functionally sequestering dynamin via the SH3 domain of TULA binding proline-rich sequences in dynamin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382318     DOI: 10.1016/j.yexcr.2007.02.017

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  De-coding genetic risk variants in type 1 diabetes.

Authors:  Melanie R Shapiro; Puchong Thirawatananond; Leeana Peters; Robert C Sharp; Similoluwa Ogundare; Amanda L Posgai; Daniel J Perry; Todd M Brusko
Journal:  Immunol Cell Biol       Date:  2021-02-24       Impact factor: 5.126

2.  Determination of the substrate specificity of protein-tyrosine phosphatase TULA-2 and identification of Syk as a TULA-2 substrate.

Authors:  Xianwen Chen; Lige Ren; Soochong Kim; Nicholas Carpino; James L Daniel; Satya P Kunapuli; Alexander Y Tsygankov; Dehua Pei
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

3.  Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane.

Authors:  Leiliane P Sousa; Irit Lax; Hongying Shen; Shawn M Ferguson; Pietro De Camilli; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

4.  UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling.

Authors:  Yan Ge; Taylor K Paisie; Jeremy R B Newman; Lauren M McIntyre; Patrick Concannon
Journal:  Diabetes       Date:  2017-06-12       Impact factor: 9.461

Review 5.  Dynamin 2 and human diseases.

Authors:  Anne-Cécile Durieux; Bernard Prudhon; Pascale Guicheney; Marc Bitoun
Journal:  J Mol Med (Berl)       Date:  2010-02-03       Impact factor: 4.599

6.  UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.

Authors:  Yan Ge; Taylor K Paisie; Sixue Chen; Patrick Concannon
Journal:  J Immunol       Date:  2019-10-28       Impact factor: 5.422

7.  Atypical protein phosphatases: emerging players in cellular signaling.

Authors:  Daichi Sadatomi; Susumu Tanimura; Kei-Ichi Ozaki; Kohsuke Takeda
Journal:  Int J Mol Sci       Date:  2013-02-26       Impact factor: 5.923

8.  SNX4 in complex with clathrin and dynein: implications for endosome movement.

Authors:  Sigrid S Skånland; Sébastien Wälchli; Andreas Brech; Kirsten Sandvig
Journal:  PLoS One       Date:  2009-06-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.